GA HB1493

Starting July 1, 2024, the Georgia Board of Nursing must immediately transmit to the Georgia Composite Medical Board copies of complaints or reports about nurse-provided care in outpatient settings requiring physician involvement, such as ordering, procuring, administering, or prescribing prescription products under nurse protocol agreements.

By December 31, 2024, the Board of Nursing must retroactively transmit to the Composite Medical Board all such complaints and reports received between January 1, 2021, and June 30, 2024, along with any related investigative materials.

The Georgia Composite Medical Board must maintain the same confidentiality protections for all transmitted complaints, reports, and investigative materials as required of the Board of Nursing.

Complaints or reports related to medications provided or administered by a nurse through a home health agency are exempt from the transmission requirement.

"Prescription product" is defined to include FDA-designated prescription medical devices and any human drugs that federal law requires to be dispensed only by prescription.